Woodline Partners’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $95.5M | Buy |
|
|||||
|
2025
Q2 | $52.3M | Buy |
|
|||||
|
2025
Q1 | $43.4M | Buy |
|
|||||
|
2024
Q4 | $22.5M | Buy |
|
|||||
|
2024
Q3 | $21M | Sell |
|
|||||
|
2024
Q2 | $28.5M | Buy |
|
|||||
|
2024
Q1 | $18.4M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $11.8M | Sell |
|
|||||
|
2023
Q1 | $14.2M | Buy |
|
|||||
|
2022
Q4 | $5.59M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $3.07M | Sell |
|
|||||
|
2022
Q1 | $13.9M | Buy |
|
|||||
|
2021
Q4 | $16.9M | Buy |
|